Sally M. Lansley

Crawley, WA, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Mesothelioma location influences the tumour microenvironment and immune checkpoint therapy response in preclinical models.

Mesothelioma location influences the tumour microenvironment and immune checkpoint therapy response in preclinical models.

Journal: Scientific reports

Published: November 03, 2025

Geldanamycin treatment does not result in anti-cancer activity in a preclinical model of orthotopic mesothelioma.

Geldanamycin treatment does not result in anti-cancer activity in a preclinical model of orthotopic mesothelioma.

Journal: PloS one

Published: September 11, 2022

PPARα and PPARγ activation is associated with pleural mesothelioma invasion but therapeutic inhibition is ineffective.

PPARα and PPARγ activation is associated with pleural mesothelioma invasion but therapeutic inhibition is ineffective.

Journal: iScience

Published: July 23, 2021

Combination immune checkpoint blockade as an effective therapy for mesothelioma.

Combination immune checkpoint blockade as an effective therapy for mesothelioma.

Journal: Oncoimmunology

Published: April 11, 2018

Streptococcus pneumoniae potently induces cell death in mesothelial cells.

Streptococcus pneumoniae potently induces cell death in mesothelial cells.

Journal: PloS one

Published: November 21, 2017

Human pleural fluid is a potent growth medium for Streptococcus pneumoniae.

Human pleural fluid is a potent growth medium for Streptococcus pneumoniae.

Journal: PloS one

Published: June 20, 2017

Role of MCP-1 in pleural effusion development in a carrageenan-induced murine model of pleurisy.

Role of MCP-1 in pleural effusion development in a carrageenan-induced murine model of pleurisy.

Journal: Respirology (Carlton, Vic.)

Published: June 13, 2016

Malignant pleural fluid from mesothelioma has potent biological activities.

Malignant pleural fluid from mesothelioma has potent biological activities.

Journal: Respirology (Carlton, Vic.)

Published: January 15, 2016

A Subset of Malignant Mesothelioma Tumors Retain Osteogenic Potential.

A Subset of Malignant Mesothelioma Tumors Retain Osteogenic Potential.

Journal: Scientific reports

Published: January 14, 2016

First bacteraemic human infection with Escherichia albertii.

First bacteraemic human infection with Escherichia albertii.

Journal: New microbes and new infections

Published: June 09, 2015

Mesothelial cells in tissue repair and fibrosis.

Mesothelial cells in tissue repair and fibrosis.

Journal: Frontiers in pharmacology

Published: March 12, 2015

Tissue plasminogen activator potently stimulates pleural effusion via a monocyte chemotactic protein-1-dependent mechanism.

Tissue plasminogen activator potently stimulates pleural effusion via a monocyte chemotactic protein-1-dependent mechanism.

Journal: American journal of respiratory cell and molecular biology

Published: December 05, 2014

Showing 1-12 of 16

Last Updated: 09/26/2026